SCHEMBL2835140

SCHEMBL2835140

CC(CCCCCCC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 15/20 0.53
LTB4R Q15722 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2835142 0.86 KIF11 (0.45) KIF11
SCHEMBL2840134 0.81 KIF11 (0.46) KIF11
SCHEMBL34261 0.80 KIF11 (0.56) KIF11
SCHEMBL13498084 0.79 KIF11 (0.71) KIF11
SCHEMBL27608746 0.79 KIF11 (0.78) KIF11
SCHEMBL4397129 0.79 KIF11 (0.78) KIF11
SCHEMBL2840135 0.78 KIF11 (0.43) KIF11
SCHEMBL6026088 0.77 FFAR4 (0.45) KIF11
SCHEMBL3427137 0.77 FFAR4 (0.45) KIF11
SCHEMBL1885698 0.77 LTB4R (0.47) KIF11LTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100228012-A1 PENDANT FATTY ACID IMAGING AGENTS MOLECULAR INSIGHT PHARMACEUTICALS, INC. 2010-09-09 US disclosed
US-7556794-B2 Pendant fatty acid imaging agents MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) 2009-07-07 US disclosed
US-20070128119-A1 Pendant fatty acid imaging agents MOLECULAR INSIGHT PHARMACEUTICALS, INC. 2007-06-07 US disclosed
US-7179444-B2 Pendant fatty acid imaging agents MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) 2007-02-20 US disclosed
EP-1490114-A1 PENDANT FATTY ACID IMAGING AGENTS Biostream, Inc. (US) 2004-12-29 EP disclosed
US-20040081616-A1 Pendant fatty acid imaging agents BIOSTREAM, INC. 2004-04-29 US disclosed
WO-2003084575-A1 PENDANT FATTY ACID IMAGING AGENTS BIOSTREAM, INC. (US) 2003-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070128119-A1 Pendant fatty acid imaging agents FABP3, CPT1B, FABP1 KIF11 1443/4885LTB4R 982/4885
US-20100228012-A1 PENDANT FATTY ACID IMAGING AGENTS FABP3, CPT1B, FABP1 KIF11 1443/4885LTB4R 982/4885
US-20040081616-A1 Pendant fatty acid imaging agents FABP3, CPT1B, FABP1 KIF11 1443/4885LTB4R 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.